229 related articles for article (PubMed ID: 2149119)
1. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.
Laspia MF; Rice AP; Mathews MB
Genes Dev; 1990 Dec; 4(12B):2397-408. PubMed ID: 2149119
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.
Laspia MF; Rice AP; Mathews MB
Cell; 1989 Oct; 59(2):283-92. PubMed ID: 2553266
[TBL] [Abstract][Full Text] [Related]
3. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M; Mathews MB
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
[TBL] [Abstract][Full Text] [Related]
4. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
Song CZ; Loewenstein PM; Green M
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769
[TBL] [Abstract][Full Text] [Related]
6. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
[TBL] [Abstract][Full Text] [Related]
7. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
9. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
10. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
Tao J; Frankel AD
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps.
Jeang KT; Berkhout B
J Biol Chem; 1992 Sep; 267(25):17891-9. PubMed ID: 1517225
[TBL] [Abstract][Full Text] [Related]
12. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes.
Ohana B; Moore PA; Ruben SM; Southgate CD; Green MR; Rosen CA
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):138-42. PubMed ID: 8419915
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro.
Bohan CA; Kashanchi F; Ensoli B; Buonaguro L; Boris-Lawrie KA; Brady JN
Gene Expr; 1992; 2(4):391-407. PubMed ID: 1282057
[TBL] [Abstract][Full Text] [Related]
14. Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.
Song CZ; Loewenstein PM; Green M
J Virol; 1995 May; 69(5):2907-11. PubMed ID: 7707515
[TBL] [Abstract][Full Text] [Related]
15. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein.
Hottiger MO; Nabel GJ
J Virol; 1998 Oct; 72(10):8252-6. PubMed ID: 9733868
[TBL] [Abstract][Full Text] [Related]
16. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
[TBL] [Abstract][Full Text] [Related]
17. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.
Tada H; Rappaport J; Lashgari M; Amini S; Wong-Staal F; Khalili K
Proc Natl Acad Sci U S A; 1990 May; 87(9):3479-83. PubMed ID: 2159152
[TBL] [Abstract][Full Text] [Related]
18. The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter.
Cupelli LA; Hsu MC
J Virol; 1995 Apr; 69(4):2640-3. PubMed ID: 7884917
[TBL] [Abstract][Full Text] [Related]
19. The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.
Delling U; Roy S; Sumner-Smith M; Barnett R; Reid L; Rosen CA; Sonenberg N
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6234-8. PubMed ID: 2068104
[TBL] [Abstract][Full Text] [Related]
20. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
Zhou Q; Chen D; Pierstorff E; Luo K
EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
